CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 52 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2019. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,394,406 | -39.0% | 341,350 | -24.8% | 0.00% | -40.0% |
Q2 2023 | $15,392,430 | -14.2% | 453,634 | -9.0% | 0.01% | -16.7% |
Q1 2023 | $17,944,783 | +80251.0% | 498,754 | -0.5% | 0.01% | -14.3% |
Q4 2022 | $22,333 | -99.9% | 501,076 | -6.3% | 0.01% | +16.7% |
Q3 2022 | $15,026,000 | -8.9% | 534,515 | -12.6% | 0.01% | 0.0% |
Q2 2022 | $16,497,000 | -18.2% | 611,872 | +3.3% | 0.01% | 0.0% |
Q1 2022 | $20,176,000 | +16.1% | 592,358 | +31.8% | 0.01% | +20.0% |
Q4 2021 | $17,373,000 | -10.3% | 449,597 | +25.4% | 0.01% | -16.7% |
Q3 2021 | $19,362,000 | +61.1% | 358,634 | -0.2% | 0.01% | +50.0% |
Q2 2021 | $12,020,000 | +92.4% | 359,424 | +18.5% | 0.00% | +100.0% |
Q1 2021 | $6,249,000 | +15.8% | 303,352 | -1.5% | 0.00% | 0.0% |
Q4 2020 | $5,395,000 | +18.0% | 307,915 | -0.1% | 0.00% | 0.0% |
Q3 2020 | $4,571,000 | +14.6% | 308,193 | +0.5% | 0.00% | 0.0% |
Q2 2020 | $3,987,000 | +594.6% | 306,723 | -11.3% | 0.00% | – |
Q1 2020 | $574,000 | -23.2% | 345,916 | +3.3% | 0.00% | – |
Q4 2019 | $747,000 | +4.8% | 334,856 | 0.0% | 0.00% | – |
Q3 2019 | $713,000 | -20.5% | 334,856 | 0.0% | 0.00% | – |
Q2 2019 | $897,000 | -30.9% | 334,856 | +26.9% | 0.00% | -100.0% |
Q1 2019 | $1,298,000 | – | 263,839 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |